Related Experiment Video

Updated: May 23, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Role for the left atrial appendage occlusion device in managing thromboembolic risk in atrial fibrillation

M N Obeyesekere1, S Lockwood, P Mottram

  • 1Monash Cardiovascular Research Centre, Monash Heart and Monash University Department of Medicine, Southern Health Network, Melbourne, Victoria, Australia. manojobey@yahoo.com

Internal Medicine Journal
|March 22, 2012
PubMed

Insights

For atrial fibrillation (AF) patients, warfarin poses risks. A new percutaneous left atrial appendage (LAA) occlusion device offers an alternative to manage thromboembolic risk, especially for those unsuitable for anticoagulation.

Area of Science:

  • Cardiology
  • Medical Devices
  • Interventional Procedures

Background:

  • Warfarin therapy for atrial fibrillation (AF) is underutilized due to bleeding risks.
  • Current percutaneous AF treatments do not fully address thromboembolic risk.
  • Anticoagulation is crucial for preventing stroke in non-valvular AF patients.

Purpose of the Study:

  • To introduce the WATCHMAN percutaneous left atrial appendage (LAA) occluder as a novel therapeutic option.
  • To present the first case of LAA occlusion performed in Australia.
  • To explore the methodology and potential of this new approach for thromboembolic risk management in AF.

Main Methods:

  • Percutaneous implantation of the WATCHMAN device.
  • Focus on left atrial appendage occlusion for stroke prevention.
  • Case presentation of the procedure in an Australian patient.

Main Results:

  • Successful implantation of the WATCHMAN device in the presented case.
  • Demonstration of a new percutaneous method for LAA occlusion.
  • Exploration of the device's role in managing thromboembolic risk.

Conclusions:

  • The WATCHMAN device represents a significant therapeutic advancement for select AF patients.
  • Percutaneous LAA occlusion offers an alternative to chronic anticoagulation for stroke prevention.
  • This case highlights the feasibility and potential of LAA occlusion in Australia.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...